Rapid Analysis of Angiogenesis Drugs in a Live Fluorescent Zebrafish Assay

Laura M. Cross,Marisa A. Cook,Shuo Lin,Jau-Nian Chen,Amy L. Rubinstein

DOI: https://doi.org/10.1161/01.atv.0000068685.72914.7e

2003-01-01

Abstract:HomeArteriosclerosis, Thrombosis, and Vascular BiologyVol. 23, No. 5Rapid Analysis of Angiogenesis Drugs in a Live Fluorescent Zebrafish Assay Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissionsDownload Articles + Supplements ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toSupplemental MaterialFree AccessLetterPDF/EPUBRapid Analysis of Angiogenesis Drugs in a Live Fluorescent Zebrafish Assay Laura M. Cross, Marisa A. Cook, Shuo Lin, Jau-Nian Chen and Amy L. Rubinstein Laura M. CrossLaura M. Cross Zygogen, LLC (L.M.C., M.A.C., S.L., A.L.R.), Atlanta, GA; and Department of Molecular, Cellular, and Developmental Biology (S.L., J.-N.C.), University of California, Los Angeles Search for more papers by this author , Marisa A. CookMarisa A. Cook Zygogen, LLC (L.M.C., M.A.C., S.L., A.L.R.), Atlanta, GA; and Department of Molecular, Cellular, and Developmental Biology (S.L., J.-N.C.), University of California, Los Angeles Search for more papers by this author , Shuo LinShuo Lin Zygogen, LLC (L.M.C., M.A.C., S.L., A.L.R.), Atlanta, GA; and Department of Molecular, Cellular, and Developmental Biology (S.L., J.-N.C.), University of California, Los Angeles Search for more papers by this author , Jau-Nian ChenJau-Nian Chen Zygogen, LLC (L.M.C., M.A.C., S.L., A.L.R.), Atlanta, GA; and Department of Molecular, Cellular, and Developmental Biology (S.L., J.-N.C.), University of California, Los Angeles Search for more papers by this author and Amy L. RubinsteinAmy L. Rubinstein Zygogen, LLC (L.M.C., M.A.C., S.L., A.L.R.), Atlanta, GA; and Department of Molecular, Cellular, and Developmental Biology (S.L., J.-N.C.), University of California, Los Angeles Search for more papers by this author Originally published1 May 2003https://doi.org/10.1161/01.ATV.0000068685.72914.7EArteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:911–912To the Editor:Solid tumors require an adequate supply of blood vessels to survive, grow, and metastasize.1–3 New blood vessels that nourish growing tumors form by angiogenesis. Drugs shown to have anti-angiogenic activity are currently in clinical cancer trials.4 To date, anti-angiogenic drugs have had mixed success in clinical application. Many new compounds may need to be tested to identify drugs capable of treating a wide range of tumors. The ideal assay for screening new compounds should involve blood vessels growing in their natural environment, such as a whole living organism, yet be amenable to rapid analysis. No current assays provide such a unique combination. We describe here an assay using the zebrafish (Danio rerio) that provides the relevance of an in vivo environment as well as the potential for high throughput drug screening.The zebrafish has become a well accepted model for studies of vertebrate developmental biology. The vascular system has been well described and shown to be highly conserved in the zebrafish.5,6 Many zebrafish blood vessels form by angiogenic sprouting and appear to require the same proteins that are necessary for blood vessel growth in mammals. In addition, anti-angiogenic compounds, such as PTK787/ZK222584 and SU5416, have been shown to affect the formation of zebrafish blood vessels.7,8Current methods of visualizing blood vessels in the zebrafish include whole mount in situ hybridization,9,10 detection of endogenous alkaline phosphatase activity,8 and microangiography.11 The first two methods are time consuming and involve fixation of embryos and larvae prior to analysis. Microangiography is also labor intensive and only useful for visualization of patent blood vessels in a complete circulatory system. Transgenic zebrafish with fluorescent blood vessels12,13 represent a less labor-intensive way of visualizing blood vessels in the zebrafish. We have generated a transgenic line with fluorescent blood vessels by driving expression of a green reef coral fluorescent protein (G-RCFP14) with a promoter for the vascular endothelial growth factor receptor 2 gene (VEGFR2, also referred to as Flk-1 or KDR).VEGFR2 is one of several receptors for VEGF family members in humans and is expressed specifically in blood vessels.15 Several zebrafish VEGFR2 cDNAs have been cloned and their expression pattern described.7,9,10,16 We used a 6.5-KB genomic fragment 5′ to the VEGFR2 initiation codon to drive G-RCFP expression specifically in zebrafish blood vessels. Hereafter, the stable transgenic line generated is referred to as TG(VEGFR2:G-RCFP), using standard zebrafish nomenclature. The expression pattern of G-RCFP in TG(VEGFR2:G-RCFP) embryos mirrored that of VEGFR2 in situ hybridization (not shown). Please see Figure I, available at http://atvb.ahajournals.org, for detailed fluorescent expression in TG(VEGFR2:G-RCFP) embryos.The bright, consistent fluorescence of angiogenic blood vessels in TG(VEGFR2:G-RCFP) zebrafish embryos suggested that they could provide an ideal tool for testing angiogenesis drugs. Jain et al17 described several factors that are important for the design of an optimal angiogenesis assay, including ease of experimentation, cost-effectiveness, rapidity, reproducibility, and ability to quantify vessel formation. Pairs of adult zebrafish produce thousands of eggs routinely and are relatively inexpensive to maintain, thus fulfilling the first two criteria.To test the utility of the TG(VEGFR2:G-RCFP) line for angiogenesis drug screening, we subjected embryos to compounds known to have anti-angiogenic activity, including SU541618,19 and SU6668,20 two indolinone-based small molecules demonstrated to inhibit VEGF-induced vascular endothelial cell proliferation in vitro. Furthermore, SU5416 and SU6668 have been reported to inhibit the formation of metastases and microvessel formation and increase apoptosis of both tumor cells and tumor endothelial cells in mouse xenograft models.21 SU5416 is believed to specifically target VEGF receptors,18,22 while SU6668 inhibits the basic fibroblast growth factor receptor and the platelet-derived growth factor receptor in addition to the VEGF receptors.20Zebrafish embryos from the TG(VEGFR2:G-RCFP) line were incubated overnight with SU5416 and SU6668, beginning when embryos were at the 13-somite stage (approximately 15 hours post fertilization [hpf]), before angiogenic sprouting of intersegmental and head vessels had begun. As shown in parts A through C of the Figure, both compounds completely blocked intersegmental vessel formation, while preserving fluorescence in the dorsal aorta, caudal artery, caudal veins, and major cranial vessels. In addition, blood vessels in the head that form by angiogenesis were not observed in treated embryos. Treated embryos also exhibited an enlarged pericardial cavity and evidence of blood pooling in the ventral tail. These findings are reminiscent of the phenotype observed following knockdown of VEGF-A in the zebrafish by antisense morpholino,23 suggesting that these effects result from lack of a functioning vascular system rather than nonspecific toxicity. The concentrations of the compounds required to see these effects (10 μmol/L for SU5416 and 15 μmol/L for SU6668) are similar to the plasma level of SU5416 (5 μmol/L) in patients treated in clinical trials.4,19 For each compound, 136 embryos were treated in several separate experiments, and all exhibited the phenotype shown in the Figure. Download figureDownload PowerPointA through C, Zebrafish embryos at 30 hpf; scale bar=100 μm. Yellow arrows indicate the dorsal aorta and red arrows indicate the caudal vein. A, Untreated embryo. An intersegmental vessel is indicated by the white arrow. B, Embryo treated overnight with 10 μmol/L SU5416. No intersegmental vessels were observed. Autofluorescence due to SU5416 is concentrated in the yolk (arrowhead). C, Embryo treated overnight with 15 μmol/L SU6668. No intersegmental vessels were observed. Autofluorescence due to SU6668 is concentrated in the yolk (arrowhead). D, Larva at 5 dpf, treated overnight with 15 μmol/L SU6668 and allowed to recover for 3 days in fresh water. Intersegmental vessels are reforming. Examples of vessels that are migrating abnormally are indicated by the white arrows.To determine whether angiogenesis could resume after the embryos are removed from the compounds, embryos were allowed to recover in fresh water for 24 to 72 hours after application of compounds. We found that blood vessels do begin to sprout again from the dorsal aorta, but they often appear irregular in shape and position, when compared with untreated embryos, as shown in part D of the Figure. Intersegmental blood vessel patterning is dependent on signals originating from the somites.24 While the somites in drug-treated embryos appeared normal, it is possible that molecules required for correct patterning of intersegmental vessels are not present at this later stage of development. Alternatively, drug treatment may affect expression of repulsive signals in the somites. Please see Figure II, available at http://atvb.ahajournals.org, for further experiments performed with these compounds.In conclusion, the TG(VEGFR2:G-RCFP) fish could form the basis of an in vivo assay for angiogenesis inhibitors. Zebrafish embryos arrayed in 96-well plates and subjected to a large number of different compounds have been used successfully to identify compounds that interfere with early development in the zebrafish.25 The dramatic changes in G-RCFP fluorescence that we observed after application of angiogenesis inhibitors should be easily quantifiable, and with new developments in microplate reader capabilities, it should be possible to develop a system for rapidly screening thousands of molecules per week for anti-angiogenic activity. Given the importance of this area for the identification of new drugs for cancer treatment, a simple, potentially quantitative, relatively inexpensive assay, such as that described in this letter, would be a major addition to the field of angiogenesis drug screening.1 Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996; 86: 353-364.CrossrefMedlineGoogle Scholar2 Li CY, Shan S, Cao Y, Dewhirst MW. Role of incipient angiogenesis in cancer metastasis. Cancer Met Rev. 2000; 19: 7–11.MedlineGoogle Scholar3 Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000; 407: 249–257.CrossrefMedlineGoogle Scholar4 Rosen L. Antiangiogenic strategies and agents in clinical trials. Oncologist. 2000; 5 (Suppl 1): 20–27.CrossrefMedlineGoogle Scholar5 Isogai S, Horiguchi M, Weinstein BM. The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. Dev Biol. 2001; 230: 278–301.CrossrefMedlineGoogle Scholar6 Vogel AM, Weinstein BM. Studying vascular development in the zebrafish. Trends Cardiovasc Med. 2000; 10: 352–360.CrossrefMedlineGoogle Scholar7 Chan J, Bayliss PE, Wood JM, Roberts TM. Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell. 2002; 1: 257–267.CrossrefMedlineGoogle Scholar8 Serbedzija GN, Flynn E, Willett CE. Zebrafish angiogenesis: a new model for drug screening. Angiogenesis. 1999; 3: 353–359.CrossrefMedlineGoogle Scholar9 Fouquet B, Weinstein BM, Serluca FC, Fishman MC. Vessel patterning in the embryo of the zebrafish: guidance by notochord. Dev Biol. 1997; 183: 37–48.CrossrefMedlineGoogle Scholar10 Liao W, Bisgrove BW, Sawyer H, Hug B, Bell B, Peters K, Grunwald DJ, Stainier DY. The zebrafish gene cloche acts upstream of a flk-1 homologue to regulate endothelial cell differentiation. Development. 1997; 124: 381–389.CrossrefMedlineGoogle Scholar11 Weinstein BM, Stemple DL, Driever W, Fishman MC. Gridlock, a localized heritable vascular patterning defect in the zebrafish. Nat Med. 1995; 1: 1143–1147.CrossrefMedlineGoogle Scholar12 Motoike T, Loughna S, Perens E, Roman BL, Liao W, Chau TC, Richardson CD, Kawate T, Kuno J, Weinstein BM, Stainier DYR, Sato TN. Universal GFP reporter for the study of vascular development. Genesis. 2000; 28: 75–81.CrossrefMedlineGoogle Scholar13 Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 2002; 248: 307–318.CrossrefMedlineGoogle Scholar14 Matz MV, Fradkov AF, Labas YA, Savitsky AP, Zaraisky AG, Markelov ML, Lukyanov SA. Fluorescent proteins from nonbioluminescent Anthozoa species. Nat Biotech. 2000; 17: 969–973.Google Scholar15 Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 1999; 13: 1055–1066.CrossrefMedlineGoogle Scholar16 Thompson MA, Ransom DG, Pratt SJ, MacLennan H, Kieran MW, Detrich HW, Vail B, Huber TL, Paw B, Brownlie AJ, Oates AC, Fritz A, Gates MA, Amores A, Bahary N, Talbot WS, Her H, Beier DR, Postlethwait JH, Zon LI. The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis. Dev Biol. 1998; 197: 248–269.CrossrefMedlineGoogle Scholar17 Jain RK, Schlenger K, Höckel M, Yuan F. Quantitative angiogenesis assays: progress and problems. Nat Med. 1997; 3: 1203–1208.CrossrefMedlineGoogle Scholar18 Fong TA, Shawver LK, Sun L, Tang C, App H, Powell TJ, Kim YH, Schreck R, Wang X, Risau W, Ullrich A, Hirth KP, McMahon G. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 1999; 59: 99–106.MedlineGoogle Scholar19 Mendel DB, Schreck RE, West DC, Li G, Strawn LM, Tanciongco SS, Vasile S, Shawver LK, Cherrington JM. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function. Clin Canc Res. 2000; 6: 4848–4858.MedlineGoogle Scholar20 Laird AD, Vajkoczy P, Shawver LK, Thurnher A, Liang C, Mohammadi M, Schlessinger J, Ullrich A, Hubbard SR, Blake RA, Fong TA, Strawn LM, Sun L, Tang C, Hawtin R, Tang F, Shenoy N, Hirth KP, McMahon G, Cherrington. JM. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res. 2000; 60: 4152–4160.MedlineGoogle Scholar21 Shaheen RM, Davis DW, Liu W, Zebrowski BK, Wilson MR, Bucana CD, McConkey DJ, McMahon G, Ellis LM. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res. 1999; 59: 5412–5416.MedlineGoogle Scholar22 Mendel DB, Laird AD, Smolich BD, Blake RA, Liang C, Hannah AL, Shaheen RM, Ellis LM, Weitman S, Shawver LK, Cherrington JM. Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. Anticancer Drugs. 2000; 15: 29–41.Google Scholar23 Nasevicius A, Larson J, Ekker SC. Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast. 2000; 17: 294–301.CrossrefMedlineGoogle Scholar24 Childs S, Chen J-N, Garrity DM, Fishman MC. Patterning of angiogenesis in the zebrafish embryo. Development. 2002; 129: 973–982.CrossrefMedlineGoogle Scholar25 Peterson RT, Link BA, Dowling JE, Schreiber SL. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci U S A. 2000; 97: 12965–12969.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Lanham K, Nedden M, Wise V and Taylor M (2022) Genetically inducible and reversible zebrafish model of systemic inflammation, Biology Open, 10.1242/bio.058559, 11:3, Online publication date: 15-Mar-2022. Mahon N, Slater K, O'Brien J, Alvarez Y, Reynolds A and Kennedy B (2022) Discovery and Development of the Quininib Series of Ocular Drugs, Journal of Ocular Pharmacology and Therapeutics, 10.1089/jop.2021.0074, 38:1, (33-42), Online publication date: 1-Jan-2022. Jindal S, Allawadhi P, Sinha S, Khurana A, Bharani K and Gopinath P (2022) Zebrafish as a Versatile Model for Cancer Research Zebrafish Model for Biomedical Research, 10.1007/978-981-16-5217-2_7, (143-180), . Pradella D, Deflorian G, Pezzotta A, Di Matteo A, Belloni E, Campolungo D, Paradisi A, Bugatti M, Vermi W, Campioni M, Chiapparino A, Scietti L, Forneris F, Giampietro C, Volf N, Rehman M, Zacchigna S, Paronetto M, Pistocchi A, Eichmann A, Mehlen P and Ghigna C (2021) A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis, Nature Communications, 10.1038/s41467-021-24998-6, 12:1, Online publication date: 1-Dec-2021. Dong S, Chen Z, Wang L, Liu Y, Stagos D, Lin X and Liu M (2021) Marine Bromophenol Bis(2,3,6-Tribromo-4,5-Dihydroxybenzyl)ether Inhibits Angiogenesis in Human Umbilical Vein Endothelial Cells and Reduces Vasculogenic Mimicry in Human Lung Cancer A549 Cells, Marine Drugs, 10.3390/md19110641, 19:11, (641) Wu S, Chen K, Xu T, Ma K, Gao L, Fu C, Zhang W, Jing C, Ren C, Deng M, Chen Y, Zhou Y, Pan W and Jia X (2021) Tpr Deficiency Disrupts Erythroid Maturation With Impaired Chromatin Condensation in Zebrafish Embryogenesis, Frontiers in Cell and Developmental Biology, 10.3389/fcell.2021.709923, 9 Sharif G, Campbell M, Nasir A, Sengupta S, Graham G, Kushner M, Kietzman W, Schmidt M, Pearson G, Loudig O, Fineberg S, Wellstein A and Riegel A (2021) An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer, Cancer Research, 10.1158/0008-5472.CAN-20-3625, 81:16, (4230-4241), Online publication date: 15-Aug-2021. Gamble J, Elson D, Greenwood J, Tanguay R and Kolluri S (2021) The Zebrafish Xenograft Models for Investigating Cancer and Cancer Therapeutics, Biology, 10.3390/biology10040252, 10:4, (252) Liu M, Li P, Tang X, Luo X, Liu K, Zhang Y, Wang Q and Li G (2020) Lemnardosinanes A-I: New Bioactive Sesquiterpenoids from Soft Coral Lemnalia sp. , The Journal of Organic Chemistry, 10.1021/acs.joc.0c02463, 86:1, (970-979), Online publication date: 1-Jan-2021. Roth S, Berens E, Sharif G, Glasgow E and Wellstein A (2021) Cancer Cell Invasion and Metastasis in Zebrafish Models (Danio rerio) Metastasis, 10.1007/978-1-0716-1350-4_1, (3-16), . Calisesi G, Candeo A, Farina A, D’Andrea C, Magni V, Valentini G, Pistocchi A, Costa A and Bassi A (2020) Three-dimensional bright-field microscopy with isotropic resolution based on multi-view acquisition and image fusion reconstruction, Scientific Reports, 10.1038/s41598-020-69730-4, 10:1, Online publication date: 1-Dec-2020. Nathan J and Kannan R (2020) Antiangiogenic molecules from marine actinomycetes and the importance of using zebrafish model in cancer research, Heliyon, 10.1016/j.heliyon.2020.e05662, 6:12, (e05662), Online publication date: 1-Dec-2020. Chen K, Fan Y, Gu J, Han Z, Zeng H, Mao C and Wang C (2020) In vivo Screening of Natural Products Against Angiogenesis and Mechanisms of Anti-Angiogenic Activity of Deoxysappanone B 7,4ʹ-Dimethyl Ether, Drug Design, Development and Therapy, 10.2147/DDDT.S252681, Volume 14, (3069-3078) Wang Q, Tang X, Liu H, Luo X, Sung P, Li P and Li G (2020) Clavukoellians G–K, New Nardosinane and Aristolane Sesquiterpenoids with Angiogenesis Promoting Activity from the Marine Soft Coral Lemnalia sp., Marine Drugs, 10.3390/md18030171, 18:3, (171) He S, Tian Y, Feng S, Wu Y, Shen X, Chen K, He Y, Sun Q, Li X, Xu J, Wen Z and Qu J (2020) In vivo single-cell lineage tracing in zebrafish using high-resolution infrared laser-mediated gene induction microscopy, eLife, 10.7554/eLife.52024, 9 Lv H, Liu B and Qin Y (2020) Isosorbide mononitrate promotes angiogenesis in embryonic development of zebrafish, Genetics and Molecular Biology, 10.1590/1678-4685-gmb-2019-0233, 43:3 Sidhwani P, Leerberg D, Boezio G, Capasso T, Yang H, Chi N, Roman B, Stainier D and Yelon D (2020) Cardiac function modulates endocardial cell dynamics to shape the cardiac outflow tract, Development, 10.1242/dev.185900 Guerra J, Tobia C, Presta M and Barbieri A (2020) Zebrafish embryo as an experimental model to study tumor angiogenesis Tumor Vascularization, 10.1016/B978-0-12-819494-2.00008-0, (129-145), . Traver D and Yoder J (2020) Immunology The Zebrafish in Biomedical Research, 10.1016/B978-0-12-812431-4.00019-1, (191-216), . Li T, Tang X, Luo X, Wang Q, Liu K, Zhang Y, de Voogd N, Yang J, Li P and Li G (2019) Agelanemoechine, a Dimeric Bromopyrrole Alkaloid with a Pro-Angiogenic Effect from the South China Sea Sponge Agelas nemoechinata , Organic Letters, 10.1021/acs.orglett.9b03683, 21:23, (9483-9486), Online publication date: 6-Dec-2019. Liao S, Han L, Zheng X, Wang X, Zhang P, Wu J, Liu R, Fu Y, Sun J, Kang X, Liu K, Fan T, Li S and Zheng X (2019) Tanshinol borneol ester, a novel synthetic small molecule angiogenesis stimulator inspired by botanical formulations for angina pectoris, British Journal of Pharmacology, 10.1111/bph.14714 Gawdzik J, Yue M, Martin N, Elemans L, Lanham K, Heideman W, Rezendes R, Baker T, Taylor M and Plavicki J (2018) sox9b is required in cardiomyocytes for cardiac morphogenesis and function, Scientific Reports, 10.1038/s41598-018-32125-7, 8:1, Online publication date: 1-Dec-2018. Li D, Xue W, Li M, Dong M, Wang J, Wang X, Li X, Chen K, Zhang W, Wu S, Zhang Y, Gao L, Chen Y, Chen J, Zhou B, Zhou Y, Yao X, Li L, Wu D and Pan W (2018) VCAM-1+ macrophages guide the homing of HSPCs to a vascular niche, Nature, 10.1038/s41586-018-0709-7, 564:7734, (119-124), Online publication date: 1-Dec-2018. Letrado P, de Miguel I, Lamberto I, Díez-Martínez R and Oyarzabal J (2018) Zebrafish: Speeding Up the Cancer Drug Discovery Process, Cancer Research, 10.1158/0008-5472.CAN-18-1029, 78:21, (6048-6058), Online publication date: 1-Nov-2018. Chen K, Wang C, Fan Y, Gu J, Han Z, Wang Y, Gao L and Zeng H (2018) Identification of mundoserone by zebrafish in�vivo screening as a natural product with anti‑angiogenic activity, Experimental and Therapeutic Medicine, 10.3892/etm.2018.6748 Chen Y, Chen P, Bao B, Shan M, Zhang K, Cheng F, Cao Y, Zhang L and Ding A (2018) Anti-thrombotic and pro-angiogenic effects of Rubia cordifolia extract in zebrafish, Journal of Ethnopharmacology, 10.1016/j.jep.2017.11.005, 219, (152-160), Online publication date: 1-Jun-2018. Berrun A, Harris E, Stachura D and Klymkowsky M (2018) Isthmin 1 (ism1) is required for normal hematopoiesis in developing zebrafish, PLOS ONE, 10.1371/journal.pone.0196872, 13:5, (e0196872) Ribatti D (2018) The Zebrafish In Vivo Models to Study Angiogenesis, 10.1016/B978-0-12-814020-8.00008-1, (75-88), . Coussens N, Braisted J, Peryea T, Sittampalam G, Simeonov A, Hall M and Gottesman M (2017) Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration–Approved Drugs, Pharmacological Reviews, 10.1124/pr.117.013755, 69:4, (479-496), Online publication date: 1-Oct-2017. Pavic A, Glišić B, Vojnovic S, Warżajtis B, Savić N, Antić M, Radenković S, Janjić G, Nikodinovic-Runic J, Rychlewska U and Djuran M (2017) Mononuclear gold(III) complexes with phenanthroline ligands as efficient inhibitors of angiogenesis: A comparative study with auranofin and sunitinib, Journal of Inorganic Biochemistry, 10.1016/j.jinorgbio.2017.06.009, 174, (156-168), Online publication date: 1-Sep-2017. Sun Q, Zhu J, Cao F, Chen F and Bach H (2017) Anti-inflammatory properties of extracts from Chimonanthus nitens Oliv. leaf, PLOS ONE, 10.1371/journal.pone.0181094, 12:7, (e0181094) Zhang W, Liu B, Feng Y, Liu J, Ma Z, Zheng J, Xia Q, Ni Y, Li F and Lin R (2017) Anti-angiogenic activity of water extract from Euphorbia pekinensis Rupr, Journal of Ethnopharmacology, 10.1016/j.jep.2017.05.033, 206, (337-346), Online publication date: 1-Jul-2017. Ganzen L, Venkatraman P, Pang C, Leung Y and Zhang M (2017) Utilizing Zebrafish Visual Behaviors in Drug Screening for Retinal Degeneration, International Journal of Molecular Sciences, 10.3390/ijms18061185, 18:6, (1185) Urbinati C, Grillo E, Chiodelli P, Tobia C, Caccuri F, Fiorentini S, David G and Rusnati M (2016) Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway, Oncogene, 10.1038/onc.2016.420, 36:18, (2609-2618), Online publication date: 4-May-2017. Yan C, Yang Q, Huo X, Li H, Zhou L and Gong Z (2017) Chemical inhibition reveals differential requirements of signaling pathways in krasV12- and Myc-induced liver tumors in transgenic zebrafish, Scientific Reports, 10.1038/srep45796, 7:1, Online publication date: 1-May-2017. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, Glasgow E, Riegel A and Wellstein A (2016) Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion, Oncogene, 10.1038/onc.2016.234, 36:5, (593-605), Online publication date: 2-Feb-2017. Jagadeeshan S, Sagayaraj R, Paneerselvan N, Ghouse S and Malathi R (2016) Toxicity and anti-angiogenicity evaluation of Pak1 inhibitor IPA-3 using zebrafish embryo model, Cell Biology and Toxicology, 10.1007/s10565-016-9358-5, 33:1, (41-56), Online publication date: 1-Feb-2017. Venero Galanternik M, Stratman A, Jung H, Butler M and Weinstein B (2016) Building the drains: the lymphatic vasculature in health and disease, WIREs Developmental Biology, 10.1002/wdev.246, 5:6, (689-710), Online publication date: 1-Nov-2016. Zhu X, Xia B, Liu H, Xu Y, Huang C, Gao J, Dong Q and Li C (2016) Closantel Suppresses Angiogenesis and Cancer Growth in Zebrafish Models, ASSAY and Drug Development Technologies, 10.1089/adt.2015.679, 14:5, (282-290), Online publication date: 1-Jul-2016. Seto S, Chang D, Jenkins A, Bensoussan A and Kiat H (2016) Angiogenesis in Ischemic Stroke and Angiogenic Effects of Chinese Herbal Medicine, Journal of Clinical Medicine, 10.3390/jcm5060056, 5:6, (56) Spikol E, Laverriere C, Robnett M, Carter G, Wolfe E and Glasgow E (2016) Zebrafish Models of Prader-Willi Syndrome: Fast Track to Pharmacotherapeutics, Diseases, 10.3390/diseases4010013, 4:1, (13) Chávez M, Aedo G, Fierro F, Allende M and Egaña J (2016) Zebrafish as an Emerging Model Organism to Study Angiogenesis in Development and Regeneration, Frontiers in Physiology, 10.3389/fphys.2016.00056, 7 Jung H, Isogai S, Kamei M, Castranova D, Gore A and Weinstein B (2016) Imaging blood vessels and lymphatic vessels in the zebrafish The Zebrafish - Cellular and Developmental Biology, Part A Cellular Biology, 10.1016/bs.mcb.2016.03.023, (69-103), . Stachura D and Traver D (2016) Cellular dissection of zebrafish hematopoiesis The Zebrafish - Cellular and Developmental Biology, Part A Cellular Biology, 10.1016/bs.mcb.2016.03.022, (11-53), . Zhu S and Thomas Look A (2016) Neuroblastoma and Its Zebrafish Model Cancer and Zebrafish, 10.1007/978-3-319-30654-4_20, (451-478), . Ignatius M, Hayes M and Langenau D (2016) In Vivo Imaging of Cancer in Zebrafish Cancer and Zebrafish, 10.1007/978-3-319-30654-4_10, (219-237), . Ristori E, Donnini S and Ziche M (2016) Studying Vascular Angiogenesis and Senescence in Zebrafish Embryos Angiogenesis Protocols, 10.1007/978-1-4939-3628-1_27, (387-400), . Anderson H, Patch T, Reddy P, Hagedorn E, Kim P, Soltis K, Chen M, Tamplin O, Frye M, MacLean G, Hübner K, Bauer D, Kanki J, Vogin G, Huston N, Nguyen M, Fujiwara Y, Paw B, Vestweber D, Zon L, Orkin S, Daley G and Shah D (2015) Hematopoietic stem cells develop in the absence of endothelial cadherin 5 expression, Blood, 10.1182/blood-2015-07-659276, 126:26, (2811-2820), Online publication date: 24-Dec-2015. Seto S, Kiat H, Lee S, Bensoussan A, Sun Y, Hoi M and Chang D (2015) Zebrafish models of cardiovascular diseases and their applications in herbal medicine research, European Journal of Pharmacology, 10.1016/j.ejphar.2015.10.031, 768, (77-86), Online publication date: 1-Dec-2015. Sharif G, Schmidt M, Yi C, Hu Z, Haddad B, Glasgow E, Riegel A and Wellstein A (2015) Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling, Oncogene, 10.1038/onc.2015.44, 34:48, (5879-5889), Online publication date: 26-Nov-2015. Liang F, Han Y, Gao H, Xin S, Chen S, Wang N, Qin W, Zhong H, Lin S, Yao X and Li S (2015) Kaempferol Identified by Zebrafish Assay and Fine Fractionations Strategy from Dysosma versipellis Inhibits Angiogenesis through VEGF and FGF Pathways, Scientific Reports, 10.1038/srep14468, 5:1, Online publication date: 1-Nov-2015. Fan Y, Li P, Chao Y, Chen H, Du N, He Q and Liu K (2015) Alkaloids with Cardiovascular Effects from the Marine-Derived Fungus Penicillium expansum Y32, Marine Drugs, 10.3390/md13106489, 13:10, (6489-6504) Kamaid A, Molina-Villa T, Mendoza V, Pujades C, Maldonado E, Ispizua Belmonte J and López-Casillas F (2015) Betaglycan knock-down causes embryonic angiogenesis defects in zebrafish, genesis, 10.1002/dvg.22876, 53:9, (583-603), Online publication date: 1-Sep-2015. Harrison M, Bussmann J, Huang Y, Zhao L, Osorio A, Burns C, Burns C, Sucov H, Siekmann A and Lien C (2015) Chemokine-Guided Angiogenesis Directs Coronary Vasculature Formation in Zebrafish, Developmental Cell, 10.1016/j.devcel.2015.04.001, 33:4, (442-454), Online publication date: 1-May-2015. Tamplin O, Durand E, Carr L, Childs S, Hagedorn E, Li P, Yzaguirre A, Speck N and Zon L (2015) Hematopoietic Stem Cell Arrival Triggers Dynamic Remodeling of the Perivascular Niche, Cell, 10.1016/j.cell.2014.12.032, 160:1-2, (241-252), Online publication date: 1-Jan-2015. Irvin M, Zijlstra A, Wikswo J and Pozzi A (2014) Techniques and assays for the study of angiogenesis, Experime